Nasal Drug Delivery Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Nasal Drug Delivery Market is Segmented by Dosage Form (Sprays, Drops and Liquids, Gels and Others), Containers, Therapeutic Application, End User and Geography

Market Snapshot

Nasal Drug Delivery Market Summary
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6.3 %
Nasal Drug Delivery Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The nasal drug delivery market will show a rapid growth owing to the increasing patient preference for nasal drug delivery as a result of easy administration and better efficacy, growing adoption of self-administration practices and the rise in demand for home healthcare devices.

The nasal drug delivery is found to be one of the most preferred drug delivery routes among patients as well as healthcare providers and this can be majorly attributed to the non-invasive nature of the drug delivery and higher drug absorbability through the nasal route. In addition, the nasal route provides a less hostile environment as compared to the other routes and this allows better absorption of drugs.

Moreover, nasal drug delivery does not require any sterile method for administering drugs into the body. Therefore the easy administration of these drugs plays a crucial role in improving the compliance to drug therapies among patients, which in turn drives the patient outcomes. Moreover, the rising patient preference for nasal products owing to increased awareness along with their efficacy and easy administration properties is anticipated to fuel the market growth.

Scope of the Report

As per the scope of the report, nasal drug delivery is the administration of the drug through the nasal route. Nasal route of administration provides direct access to the systemic circulation. The nasal drug delivery is used as a treatment of local infection in the nasal course & paranasal sinuses such as rhinitis. This technique is used to lessen the problem of slow absorption of drugs, degradation before reaching the target site, and poor bioavailability.

By Dosage Form
Drops and Liquids
By Containers
Non-Pressurized Containers
Pressurized Containers
By Therapeutic Application
Nasal Congestion
By End User
Home Health Care
North America
United States
United Kingdom
Rest of Europe
Asia Pacific
South Korea
Rest of Asia-Pacific
Middle East and Africa
South Africa
Rest of Middle East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Drops and Liquids is Expected to be the Fastest Growing Segment During the Forecast Period

Drops and liquids segment is estimated to be the fastest-growing dosage form segment with a high CAGR and its growth can be attributed to the affordability and treatment success rates of these liquid products. As there has also been a rising demand for self-administration and increasing patient compliance that is also likely to augment the market growth.

In addition, the availability of various nasal drops and liquids products in the market is expected to contribute to the segment growth over the coming years.

Nasal Drug Delivery Market: Estimated Percentage (%) of Asthma Prevalence,The United States, 2018

North America is Anticipated to Dominate the Nasal Drug Delivery Market

The North America region dominates the nasal drug delivery technology market due to the advanced technology, products launches and innovation, growing prevalence of asthma and chronic obstructive pulmonary disease and increasing adoption of early treatment procedures. As the chronic obstructive pulmonary disease is found to be the third leading cause of death in the United States, therefore the increasing prevalence of COPD may help in increasing the adoption of nasal drug delivery devices. There are also an the increasing number of individuals with asthma that helps to witness strong growth over the forecast period.

Asia Pacific is also expected to witness the fastest CAGR due to the availability of effective treatment methods, high unmet clinical needs, rising disposable income levels, and increasing awareness about these products.

Nasal Drug Delivery Market- Growth Rate By Region

Competitive Landscape

The market is likely to face intense competition over the forecast period owing to the presence of many multinational companies. Geographical expansion, new product development, and joint ventures are some of the key strategies undertaken by key market players. For instance, in 2017, Merck collaborated with Premier, Inc. (US) to develop a preventive care model that seeks to improve adolescent and adult vaccination rates.

Major Players

  1. Neurelis, Inc.

  2. Aptargroup, Inc.

  3. Becton, Dickinson and Company

  4. Astrazeneca PLC

  5. 3M Company

Nasal Drug Delivery Market Concentration

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Patient Preference for Nasal Drug Delivery as A Result of Easy Administration and Better Efficacy

      2. 4.2.2 Growing Adoption of Self-Administration Practices

      3. 4.2.3 Rise in Demand for Home Healthcare Devices

    3. 4.3 Market Restraints

      1. 4.3.1 Complications Associated With the Overuse of Nasal Sprays

      2. 4.3.2 Patent Expiry of Several Drugs

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Dosage Form

      1. 5.1.1 Sprays

      2. 5.1.2 Drops and Liquids

      3. 5.1.3 Gels

      4. 5.1.4 Others

    2. 5.2 By Containers

      1. 5.2.1 Non-Pressurized Containers

      2. 5.2.2 Pressurized Containers

    3. 5.3 By Therapeutic Application

      1. 5.3.1 Rhinitis

      2. 5.3.2 Nasal Congestion

      3. 5.3.3 Asthma

      4. 5.3.4 Others

    4. 5.4 By End User

      1. 5.4.1 Hospitals

      2. 5.4.2 Home Health Care

    5. 5.5 Geography

      1. 5.5.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.5.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.5.3 Asia Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.5.4 Middle East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East and Africa

      5. 5.5.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 3M Company

      2. 6.1.2 Neurelis, Inc.

      3. 6.1.3 Aptargroup, Inc.

      4. 6.1.4 Astrazeneca PLC

      5. 6.1.5 Becton, Dickinson and Company

      6. 6.1.6 Glaxosmithkline PLC

      7. 6.1.7 Johnson & Johnson Services, Inc.

      8. 6.1.8 Merck & Co., Inc.

      9. 6.1.9 Novartis AG

      10. 6.1.10 Pfizer Inc.

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Nasal Drug Delivery Market market is studied from 2018 - 2026.

The Nasal Drug Delivery Market is growing at a CAGR of 6.3% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Neurelis, Inc., Aptargroup, Inc., Becton, Dickinson and Company, Astrazeneca PLC, 3M Company are the major companies operating in Nasal Drug Delivery Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!